Literature DB >> 3508549

Multiple-dose pharmacokinetics of clozapine in patients.

M G Choc1, R G Lehr, F Hsuan, G Honigfeld, H T Smith, R Borison, J Volavka.   

Abstract

After a 2-day buildup, patients were dosed continuously with clozapine solution at three ascending dose levels (37.5, 75, and 150 mg bid for 7 days at each dose level). Following the morning administration on the twenty-third day of dosing a drug holiday was instituted which lasted for a minimum of 48 hr. Serial plasma samples were obtained during each of the periods and during the drug holiday for the calculation of the steady-state parameters AUCSS, CSSmax, and CSSmin at each dose level as well as for the assessment of the terminal elimination rate. Mean parameter values for AUCSS, CSSmax, and CSSmin showed a linearly increasing response with the dose, well described by a straight line passing through the origin. The terminal elimination appeared to follow linear kinetics and had a mean half-life of 15.8 hr (range, 5.8-33 hr).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3508549     DOI: 10.1023/a:1016434312388

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  3 in total

1.  Serum concentrations of clozapine determined by nitrogen selective gas chromatography.

Authors:  R Heipertz; H Pilz; W Beckers
Journal:  Arch Toxicol       Date:  1977-08-09       Impact factor: 5.153

2.  [Exchange of aromatically bound halogen for OH- and SCH3-groups in metabolising clozapine in the human organism (author's transl)].

Authors:  B Stock; G Spiteller; R Heipertz
Journal:  Arzneimittelforschung       Date:  1977

3.  The metabolism of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e) (1,4)diazepine (clozapine) in mice, dogs and human subjects.

Authors:  R Gauch; W Michaelis
Journal:  Farmaco Prat       Date:  1971-11
  3 in total
  23 in total

1.  Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patients.

Authors:  M G Choc; F Hsuan; G Honigfeld; W T Robinson; L Ereshefsky; M L Crismon; S R Saklad; J Hirschowitz; R Wagner
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

Review 2.  Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.

Authors:  Massimo Carlo Mauri; Silvia Paletta; Chiara Di Pace; Alessandra Reggiori; Giovanna Cirnigliaro; Isabel Valli; Alfredo Carlo Altamura
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

3.  Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors:  A Fitton; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

4.  Clinical pharmacokinetics of clozapine in chronic schizophrenic patients.

Authors:  Y F Cheng; T Lundberg; U Bondesson; L Lindström; J Gabrielsson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women.

Authors:  M Fabrazzo; G Esposito; R Fusco; M Maj
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 6.  What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia.

Authors:  Peter Schulte
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice.

Authors:  José L Moreno; Terrell Holloway; Adrienne Umali; Vinayak Rayannavar; Stuart C Sealfon; Javier González-Maeso
Journal:  Psychopharmacology (Berl)       Date:  2012-07-28       Impact factor: 4.530

8.  CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study.

Authors:  C Nordin; B Almé; U Bondesson
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

Review 9.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

Review 10.  Pharmacokinetics and pharmacodynamics of clozapine.

Authors:  M W Jann; S R Grimsley; E C Gray; W H Chang
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.